Should You Accept a Counter Offer in Life Sciences?

Most life sciences professionals don't resign on impulse. By the time you hand in your notice, you have usually already done the thinking. The pipeline isn't going where you need it to. The remit has stopped growing. The progression conversation has been deferred one too many times. The decision to leave is usually considered, specific, and grounded in something real.

Then the counter offer arrives. More money, a better title, access to the programme that was always six months away. And a decision that felt clear gets complicated.

The offer may be genuine. Some counter offers do represent real change and accepting them is the right call. But the factors that make them feel compelling in the moment are not always the ones that matter twelve months later. This guide explores what counter offers actually look like in life sciences, when accepting one makes sense, and how to evaluate the decision without the noise.

What is a counter offer?

A counter offer is a proposal made by your current employer after you have submitted your resignation. Its purpose is to persuade you to remain rather than join another organisation.

In life sciences, these typically include a salary increase, a change in title or seniority, or an expanded remit across functions, geographies or therapeutic areas. Sometimes it is accelerated access to a programme or submission that had not previously been on the table. Often it is a combination of several of these.

From the employer's perspective the calculation is practical. Replacing a regulatory affairs specialist, a clinical operations lead, or a medical affairs professional with genuine therapeutic area depth takes months. The institutional knowledge those professionals carry, covering agency relationships, trial history, and cross-functional working patterns, cannot be quickly rebuilt.

A counter offer addresses the immediate problem of losing someone. What it does not necessarily address are the reasons that person decided to leave in the first place. In many cases, the decision to leave was shaped by factors that developed over time rather than a single event.

Life Sciences Salary & Compensation Guides

If you are evaluating a counter offer, understanding how your compensation compares with the wider market can provide useful context. Our life sciences compensation guides provide salary benchmarks, hiring demand insights, and workforce trends across regulatory affairs, clinical development, medical affairs, and other specialist functions.

Explore the latest life sciences compensation guides

How common are counter offers in life sciences?

Counter offers are particularly prevalent where specialist expertise is difficult to replace. In a survey conducted by EPM Scientific of life sciences professionals, 57% reported receiving a counter offer after resigning. Of those who accepted, most still left the organisation within twelve months, and around half resumed their job search within weeks.

The pattern is consistent. Accepting a counter offer and remaining long term are not the same thing, and the gap between them is worth understanding before any decision is made.

From the employer’s perspective, the incentive to retain experienced professionals is significant. Research referenced by the Society for Human Resource Management suggests that replacing an employee can cost between six and nine months of their salary once recruitment, onboarding, and lost productivity are taken into account.

The demand context also matters here. In the UK alone, the Life Sciences 2035 report published in March 2025 projects that around 145,000 new and replacement workers will be needed by 2035. That pressure is not unique to one market. Across the US, Europe and Asia-Pacific, life sciences organisations are operating in the same constrained talent environment, competing for the same specialist profiles in regulatory, clinical, medical affairs and beyond. Experienced professionals in these areas often develop expertise that is highly specific to therapeutic areas, regulatory pathways, or development stages, which makes replacement both slow and operationally disruptive.

When someone with that level of expertise resigns, the cost of losing them becomes immediately visible. That is why counter offers in this sector tend to arrive quickly and with substance.

When accepting Is the right decision

If the original decision to leave was driven by a specific issue rather than broader dissatisfaction, accepting a counter offer can sometimes represent real progress. This is only true when the offer resolves that issue in a substantive and documented way. In these cases, the issue that prompted the resignation tends to be specific rather than structural.

In life sciences this might mean formal ownership of a regulatory submission rather than a supporting role on it, a confirmed step into cross-functional leadership, or written access to a late-stage pipeline programme that had not previously been available.

The word documented matters. Verbal commitments made under the pressure of a resignation are difficult to hold anyone to six months later. If the changes are genuine, they should be confirmable in writing.

It also matters how far along you are in the process with the prospective employer. The earlier a decision to stay is made and communicated, the less complicated the situation becomes for everyone involved.

When a counter offer Is unlikely to resolve the situation

A counter offer rarely changes the right outcome when the reasons for leaving are structural.

• In life sciences, structural drivers tend to look like this:
  A pipeline that no longer offers the scientific ambition or therapeutic complexity you want to work on.
• A remit that does not reflect your level of expertise.
• An organisation that has not kept pace with shifts towards advanced therapies, digital infrastructure, or data capabilities.
• A progression pathway that has reached a natural ceiling without a credible route beyond it.

These are not problems compensation alone can resolve. They reflect how a role is positioned within an organization, how its science is evolving, and what opportunities realistically exist over the next few years.

When those factors are the reason for leaving, a counter offer may delay the decision, but it rarely changes the underlying outcome.

How to evaluate a counter offer

Question To Ask	If the Answer is Yes	If the Answer Is No
Has something meaningful about the role actually changed?	The counter offer may represent a genuine shift in responsibilities or opportunity.	The offer may be focused on retention rather than resolving the original issue.
Are the changes clearly defined and confirmed in writing?	The new terms are more likely to be honored over time.	Verbal commitments made under pressure are harder to rely on later.
Does the offer resolve the reason you started looking?	Staying may address the issue that prompted the resignation.	The underlying motivation for leaving may still exist.
Would this opportunity have existed without the resignation?	The change may reflect a broader shift in how your role is valued.	The offer may be a short-term response to losing you.
Looking two to three years ahead, does staying move your career forward?	Remaining could support the direction you want your career to take.	The move you were considering may better align with your longer-term goals.

The reputational dimension

Compensation tends to be the most visible element of a counter offer. Less visible, but equally significant, are the professional implications of how the situation is handled.

Once a resignation is submitted, planning begins. Teams start preparing for transition, projects are reassigned, and leadership begins to adjust their expectations around continuity. When that decision is reversed the operational steps can be unwound, but the perception of long-term commitment can take time to rebuild.

It is not uncommon for professionals who accept counter offers to find themselves less visible when it comes to strategic programmes, particularly in late-phase clinical work or time-sensitive regulatory submissions where staff continuity carries real operational weight.

Life sciences is a smaller professional community than it often appears. Hiring managers move between CROs, pharma, and biotech throughout their careers. Specialist recruiters work with the same candidates and clients over many years. A late withdrawal, handled without transparency, can be remembered. How you communicate your decision matters as much as the decision itself.

The bigger picture

Counter offers are common in life sciences. Specialist expertise in areas such as regulatory affairs, clinical development, and medical affairs takes years to build, and organisations understand the operational impact of losing it.

What matters most is whether the offer meaningfully changes the factors that prompted the resignation in the first place. In a sector where scientific direction, pipeline access, and organisational capability shape long-term career trajectories, that distinction carries real weight.

Professionals who navigate the situation best tend to evaluate it in the context of where they want their careers to go, rather than the immediate appeal of an improved offer.

If you are weighing a counter offer and want to understand how your experience is positioned in the current market, speaking with a specialist consultant can help provide that perspective. Register with EPM Scientific to start the conversation.

Register with Us